By S. Harrish
MALAYSIA has signed a preliminary agreement with pharmaceutical company Pfizer to obtain 12.8 million doses of Covid-19 vaccines to meet the immunisation needs of 20% or 6.4 million Malaysians.
Prime Minister Tan Sri Muhyiddin Yassin said the agreement, signed on Tuesday (Nov 24), aimed to ensure the government had access to data to assess the vaccine’s quality, safety and effectiveness while also ensuring access once it was ready for distribution.
“Pfizer on Nov 9 stated that the first interim data analysis showed that the vaccine efficacy was at 95%.
“Through this agreement, Pfizer has pledged to deliver one million doses, 1.7 million doses, 5.8 million doses and 4.3 million doses of Covid-19 vaccine in the first, second, third and fourth quarters of 2021,” he told a virtual media conference, according to Bernama.
Muhyiddin said all Malaysians will be vaccinated against Covid-19 for free.
He added that the vaccines will be dispensed based on priority, with those in high-risk groups such as frontliners, receiving them before the general population.
Although the deal has been signed, Pfizer is yet to get the approval from the US Food and Drug Administration and other regulatory bodies.
“Pfizer also has to get the approval from the National Pharmaceutical Regulatory Agency under the Health Ministry before the vaccine can be used in Malaysia,” he said.